DRASA DRASA DRASA DRASA
  • Home
  • Our Story
    • About Us
    • Dr. Ameyo Stella Adadevoh
    • Our Partners
  • Our Solutions
    • Our Model
    • Our Program Areas
      • Antimicrobial Resistance (AMR)
      • Infection Prevention and Control (IPC)
      • Health Security
      • Community Health and Hygiene
    • Our Impact
  • News & Blog
  • Contact Us
    • Contact Us
    • Get Involved
    • Join Our Team
  • Resources
    • Reports
    • Newsletter Archive
    • Email Signup
  • Donate
DRASA DRASA
  • Home
  • Our Story
    • About Us
    • Dr. Ameyo Stella Adadevoh
    • Our Partners
  • Our Solutions
    • Our Model
    • Our Program Areas
      • Antimicrobial Resistance (AMR)
      • Infection Prevention and Control (IPC)
      • Health Security
      • Community Health and Hygiene
    • Our Impact
  • News & Blog
  • Contact Us
    • Contact Us
    • Get Involved
    • Join Our Team
  • Resources
    • Reports
    • Newsletter Archive
    • Email Signup
  • Donate
Jul 29

#IDFridays Week 23: Viral Hepatitis

  • July 29, 2016
  • DRASA ADMIN
  • No Comments
  • #IDFridays

This disease kills more people than AIDS, tuberculosis, or malaria each year

Photo Credits: Washington.edu, FDA.gov

Name
Viral hepatitis

  • There are five main types of viral hepatitis, but for this post we are focusing on hepatitis B and hepatitis C

Transmission

  • Hepatitis B and C are two highly contagious viral infections that attack the liver
  • Hepatitis B: the virus can live outside the body for at least 7 days and is transmitted through contact with an infected person’s blood or body fluids
    • The virus can also be transmitted sexually and from a mother to a child at birth
    • Hepatitis B is 50-100 times more contagious than HIV
  • Hepatitis C: the virus lives in the blood and is transmitted through infected blood (unsafe injections/sharing needles, inadequate sterilization of medical equipment, blood transfusions, etc.)
    • The virus can live on surfaces outside the body for up to 3 weeks
    • Hepatitis C is 10 times more contagious than HIV

Geography

  • Hepatitis B: worldwide, but especially prevalent in sub-Saharan Africa and East Asia
  • Hepatitis C: worldwide, but especially prevalent in Africa and Central and East Asia

Incubation Period

  • Hepatitis B: within 1 to 6 months of infection
  • Hepatitis C: within 2 weeks to 6 months of infection

Signs and Symptoms

Hepatitis B

  • Most people do not experience symptoms in the initial “acute” phase but some have:
    • Nausea
    • Abdominal pain
    • Vomiting
    • Jaundice (yellowing of the skin and eyes)
    • Dark urine
    • Extreme fatigue
    • Liver failure (rare)
  • Once it enters the “chronic” phase, people develop chronic liver infection which can become liver cirrhosis or liver cancer

Hepatitis C

  • 80% of infected people do not have any symptoms, but occasionally the “acute” phase symptoms include:
    • Joint pain
    • Fever
    • Decreased appetite
    • Nausea
    • Vomiting
    • Jaundice (yellowing of the skin and eyes)
    • Dark urine
  • From the “acute” phase, 75%–85% of people develop “chronic” hepatitis C

Diagnosis

  • Laboratory testing of blood samples

    • Because most people with hepatitis B and C do not have symptoms in the initial “acute” phase, diagnosis is very difficult

Treatment

Hepatitis B

  • There is no specific treatment for the “acute” phase
    • At this point the goal is to maintain the patient’s comfort and ensure they have good nutrition and fluid intake
  • For the “chronic” phase, treatment includes drugs such as oral antiviral agents to slow down the liver cirrhosis and reduce incidence of liver cancer

Hepatitis C

  • Hepatitis C does not always require treatment because some people’s immune system response can get rid of the infection and those who develop the “chronic” infection do not always develop liver damage
  • Antiviral drugs are available for patients who need them

Prognosis

Hepatitis B

  • For most people, treatment only suppresses the replication of the virus and does not cure the infection so they must continue treatment for the rest of their life
  • Children younger than 6 years old are most at risk of developing chronic infections
  • 20–30% of adults who are chronically infected will develop cirrhosis and/or liver cancer

Hepatitis C

  • The infection can last a lifetime (only 15%–25% of infected people clear the virus from their bodies) and can lead to serious liver problems, including liver cirrhosis and/or liver cancer
    • 60–70% of infected people develop chronic liver disease
    • 5–20% of infected people develop liver cirrhosis
    • 1–5% of infected people die from cirrhosis or liver cancer

Prevention: What Can You Do?

  • Hepatitis B: there is a vaccine available to protect yourself and your loved ones and it is 95% effective
  • Hepatitis C: there is no vaccine so prevention includes:
    • Handwashing and using gloves in healthcare settings
    • Ensuring injecting equipment is always sterile
    • Testing donated blood for hepatitis C
    • Using condoms

Viral Hepatitis In the News

  • Hepatitis is on the rise as a global killer
  • 20 million Nigerians are infected with hepatitis B – Experts

Sources:
https://www.cdc.gov/hepatitis/
http://www.who.int/hepatitis/en/

  • Facebook
  • Twitter
  • LinkedIn
  • E-Mail

About The Author

Leave a reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

  • #IDFridays
  • #ItStartsWithMe
  • Antimicrobial Resistance
  • Awards and Recognition
  • Community Outreach
  • DRASA Ambassadors
  • DRASA Radio Half Hour
  • Health Champions
  • Health Security
  • Humans of DRASA
  • Infection Prevention and Control
  • News
  • Outbreak Preparedness
  • Press Releases
  • Youth Engagement

Recent News

  • Sustaining Infection Prevention and Control Practices in Primary Healthcare Centers
  • The Importance of Cleaner and Safer Environments in Reducing the Burden of Infectious Diseases: Ogunsina Oluwaseun’s Story
  • ”See Something, Say Something”: Our Health Champions Are Improving Community Health and Surveillance
  • Food Safety for Overall Health Security: Strengthening the Capacity of Food Safety Officers
  • Engaging Children in The Fight Against Infectious Diseases: Sulaimon Kaosarat’s Health Champion Story.
Preventing Disease.
Protecting Health.
Preserving a Legacy.

Recent Posts

  • Sustaining Infection Prevention and Control Practices in Primary Healthcare Centers
  • The Importance of Cleaner and Safer Environments in Reducing the Burden of Infectious Diseases: Ogunsina Oluwaseun’s Story
  • ”See Something, Say Something”: Our Health Champions Are Improving Community Health and Surveillance
  • Food Safety for Overall Health Security: Strengthening the Capacity of Food Safety Officers
  • Engaging Children in The Fight Against Infectious Diseases: Sulaimon Kaosarat’s Health Champion Story.

Contact Info

17 Ibikunle Street, Yaba, Lagos, Nigeria | 50 Ebitu Ukiwe Street, Jabi, Abuja, Nigeria Phone: +234 803 613 1484 E-Mail: info@drasatrust.org

NEWSLETTER

* indicates required

Connect With Us

© 2025 Dr. Ameyo Stella Adadevoh Health Trust - All Rights Reserved.